1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Application
3.2. Snippet by Drug class
3.3. Snippet by End user
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Launch of therapeutically effective drugs
4.1.2. Restraints
4.1.2.1. Rising prices of dermatology drugs
4.1.3. Opportunity
4.1.3.1. Rise in elderly population
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s 5 forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID-19
6.1.2. Scenario During COVID-19
6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers’ Strategic Initiatives
6.6. Conclusion
7. By Drug Class
7.1 Atopic Dermatitis
7.2 Psoriasis
7.3 Acne
7.4 Alopecia
7.5 Herpes
7.6 Rosacea
8. By Drug Class
8.1. Anti-Infectives
8.2. Anti-Acne
8.3. Calcineurin Inhibitors
8.4. Retinoids
8.5. Corticosteroids
8.6. Other Drug classes
9. By End user
9.1. Hospitals
9.2. Dermatology Clinics
9.3. Cosmetic Centers
9.4 Others
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Drug class
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user
10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.6.1. The U.S.
10.2.6.2. Canada
10.2.6.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Drug class
10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user
10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.6.1. Germany
10.3.6.2. The UK
10.3.6.3. France
10.3.6.4. Italy
10.3.6.5. Spain
10.3.6.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Drug class
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user
10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.6.1. Brazil
10.4.6.2. Argentina
10.4.6.3. Rest of South America
10.5. Asia-Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Drug class
10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user
10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.6.1. China
10.5.6.2. India
10.5.6.3. Japan
10.5.6.4. Australia
10.5.6.5. Rest of Asia-Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Drug class
10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user
10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11. Competitive Landscape
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. Company Profiles
12.1. Leo Pharma
12.2. Allergan Inc.
12.3. Amgen Inc.
12.4. GI Dermatics
12.5. Sanofi
12.6. Merck & Co.
12.7. Pfizer
12.8. AbbVie
12.9. Bausch Health
12.10. Novartis
13. Appendix
13.1. About Us and Services
13.2. Contact Us